SCHEMBL30361009

SCHEMBL30361009

c1ccc2c(c1)c1ccccc1n2-c1ccc2c(c1)Oc1cc(-n3c4ccccc4c4ccccc43)ccc1N2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ ALOX5 P09917 4/20 0.42
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ EDNRB P24530 1/20 0.36
▸ EDNRA P25101 1/20 0.36
▸ HTR2B P41595 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ GPR3 P46089 1/20 0.31
▸ PTPN1 P18031 2/20 0.31
▸ POLB P06746 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17265886 1.00 KDM4E (0.46) KDM4EATML3MBTL1ALOX5NPC1
SCHEMBL30361019 0.95 ALOX5 (0.52) KDM4EATML3MBTL1ALOX5NPC1
SCHEMBL17265891 0.95 ALOX5 (0.52) KDM4EATML3MBTL1ALOX5NPC1
SCHEMBL29689637 0.88 L3MBTL1 (0.44) KDM4EATML3MBTL1ALOX5NPC1
SCHEMBL2388968 0.82 KDM4E (0.52) KDM4EATML3MBTL1NPC1RAB9A
SCHEMBL12259308 0.82 KDM4E (0.52) KDM4EATML3MBTL1NPC1RAB9A
SCHEMBL16889722 0.79 KDM4E (0.39) KDM4EATML3MBTL1NPC1RAB9A
SCHEMBL6123827 0.78 KDM4E (0.52) KDM4EATML3MBTL1NPC1RAB9A
SCHEMBL24307493 0.77 KDM4E (0.46) KDM4EATML3MBTL1NPC1RAB9A
SCHEMBL13141861 0.77 KDM4E (0.46) KDM4EATML3MBTL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12565613-B2 Quantum dots with donor-acceptor ligands SHOEI CHEMICAL INC. (JP) 2026-03-03 — — US disclosed
US-20230036119-A1 QUANTUM DOTS WITH DONOR-ACCEPTOR LIGANDS NANOSYS, INC. 2023-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12565613-B2 Quantum dots with donor-acceptor ligands HCCS, FDPS, FTH1 KDM4E 4066/4885ATM 4468/4885L3MBTL1 1975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback